Efficacy of Subcutaneous Tocilizumab for the Treatment of Refractory Large Vessel Vasculitis in a Patient with Latent Tuberculosis Infection | Zendy

AI Assistant Blog Pricing

Efficacy of Subcutaneous Tocilizumab for the Treatment of Refractory Large Vessel Vasculitis in a Patient with Latent Tuberculosis Infection

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.